Novogen, Ltd. (ASX: NRT)'s over-the-counter red clover natural supplement marketed under the brand name Promensil has been found to both effective and safe for the treatment of menopausal symptoms, particularly hot flashes.

This finding is reported in a paper by eight internationally renowned women's health experts published in the April issue (abstract, a pdf file) of The Journal of Obstetrics & Gynecology of Canada.

The scientists have recommended that Promensil should be among the first lines of defense in the treatment of the symptoms of menopause - a first for scientists to arrive at a consensus suggesting dietary supplements as among the first lines of defense in the treatment of the symptoms of menopause.

"Hot flashes are the leading reason menopausal women seek treatment during menopause," said Dr. Lila Nachtigall, MD, professor of obstetrics and gynecology at New York University's School of Medicine, and the lead author of the paper.

"In our research, we found a growing trend away from prescription hormone therapy (HT) in women with mild to moderate symptoms and an increasing trend toward lifestyle modifications and complementary therapies."

Promensil contains red-clover derived isoflavones manufactured and marketed by Novogen, Ltd.

Promensil have been clinically proven to be safe and effective in treating the symptoms of menopause and improving heart, breast and bone health.

Read more details at the full press release.